Taysha Gene Therapies
TSHA
TSHA
48 hedge funds and large institutions have $388M invested in Taysha Gene Therapies in 2021 Q2 according to their latest regulatory filings, with 10 funds opening new positions, 26 increasing their positions, 5 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
1.54% more ownership
Funds ownership: 46.77% → 48.31% (+1.5%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
Holders
48
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$15M | |
| 2 | +$8.38M | |
| 3 | +$6.07M | |
| 4 |
State Street
Boston,
Massachusetts
|
+$4.17M |
| 5 |
JPMorgan Chase & Co
New York
|
+$3.97M |
Top Sellers
| 1 | -$16.7M | |
| 2 | -$16.7M | |
| 3 | -$3.18M | |
| 4 |
VA
VR Adviser
New York
|
-$2.45M |
| 5 |
ACH
ArrowMark Colorado Holdings
Denver,
Colorado
|
-$2.35M |